SCHEMBL1629183

SCHEMBL1629183

COc1cc(OC)c(S(=O)(=O)N2CCCCC2CO)cc1-c1ccnn1-c1ccccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.40
OPRK1 P41145 1/20 0.40
ALOX5AP P20292 4/20 0.38
FEN1 P39748 3/20 0.38
ALDH1A1 P00352 5/20 0.37
LMNA P02545 3/20 0.37
HSD17B10 Q99714 2/20 0.37
RORC P51449 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
TP53 P04637 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KMT2A Q03164 2/20 0.37
HSP90AA1 P07900 1/20 0.37
MEN1 O00255 1/20 0.37
USP2 O75604 1/20 0.37
HTT P42858 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HTR1A P08908 1/20 0.36
HTR7 P34969 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1628950 0.86 HSP90AA1 (0.45) OPRM1OPRK1ALOX5APFEN1ALDH1A1
SCHEMBL1628804 0.84 TSHR (0.52) ALDH1A1LMNAHSD17B10KDM4EMAPT
SCHEMBL1630245 0.79 TSHR (0.48) ALDH1A1LMNAHSD17B10KDM4ETP53
SCHEMBL1630418 0.79 HSP90AA1 (0.41) ALDH1A1LMNAHSD17B10MAPTTP53
SCHEMBL1219165 0.78 HSP90AA1 (0.40) ALDH1A1LMNAHSD17B10MAPTTP53
SCHEMBL1628849 0.77 MEN1 (0.45) ALDH1A1LMNAKDM4EMAPTTP53
SCHEMBL1628788 0.77 HSP90AA1 (0.41) ALDH1A1LMNAHSD17B10MAPTTP53
SCHEMBL1629173 0.75 HSP90AA1 (0.38) ALDH1A1HSD17B10KDM4EHSP90AA1HTT
SCHEMBL1631546 0.75 HSP90AA1 (0.40) ALDH1A1LMNATP53SMN1; SMN2HSP90AA1
SCHEMBL1631566 0.75 TSHR (0.44) ALDH1A1LMNAHSD17B10MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed
EP-1776346-A1 1,5-DIPHENYLPYRAZOLES Merck Patent GmbH (DE) 2007-04-25 EP disclosed
WO-2006018082-A1 1,5-DIPHENYLPYRAZOLES MERCK PATENT GMBH (DE) 2006-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P OPRM1 3646/4885OPRK1 2566/4885ALOX5AP 4262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.